O PIONEERs! The Beginning of the End of Full-Dose Triple Therapy with Warfarin?

Affiliations

Editorial

Deepak L Bhatt. Circulation. 2017.

. 2017 Jan 24;135(4):334-337.

doi: 10.1161/CIRCULATIONAHA.116.025923. Epub 2016 Nov 14.

¹ From Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA. dlbhattmd@post.harvard.edu.

No abstract available

Keywords: Editorials.

Comment on

Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.
Gibson CM, Pinto DS, Chi G, Arbetter D, Yee M, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, Burton P, van Eickels M, Korjian S, Daaboul Y, Jain P, Lip GY, Cohen M, Peterson ED, Fox KA. Gibson CM, et al. Circulation. 2017 Jan 24;135(4):323-333. doi: 10.1161/CIRCULATIONAHA.116.025783. Epub 2016 Nov 14. Circulation. 2017. PMID: 27881555 Free PMC article. Clinical Trial.